# Vital Software

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vital-software-2

- Industry: Software
- Headquarters: Atlanta, US
- Website: www.vitaler.com
- Total disclosed funding: $38M
- Latest round: Series B (Dec 1, 2022)
- Investors on record: 10

## About

Vital Software Inc. develops AI-driven solutions that enhance patient experiences in healthcare, focusing on effective communication between patients and providers.Founded in 2017 and headquartered in Atlanta, US, Vital Software Inc. specializes in healthcare technology aimed at improving patient-provider interactions. Co-founded by Aaron Patzer, Justin Schrager, and Wilson Lau, the company has successfully closed three deals, with the most recent being a Series B funding round in December 2022, where they raised USD 17.70 mn led by Transformation Capital. The total amount raised by the company stands at USD 17.70 mn, with a current valuation of USD 91.60 mn.Vital Software offers AI-driven tools to optimize the patient experience in healthcare settings. Their flagship product includes a doctor-to-patient translation engine that simplifies medical language, enhancing patient comprehension. Additionally, the platform utilizes live Electronic Health Record (EHR) data to streamline patient care by predicting wait times and improving discharge processes, thereby supporting healthcare providers in delivering better patient engagement and operational efficiency.Vital Software generates revenue through a subscription model tailored for hospitals and healthcare systems. Their services are integrated with existing EHR systems, enhancing patient experiences. Although specific pricing details are not disclosed, the company provides customizable product versions that align with client needs, promoting a return on investment by boosting patient scores and specialist follow-ups, thus enhancing overall revenue growth for healthcare organizations utilizing their solutions.In December 2022, Vital Software Inc. raised USD 17.70 mn in Series B funding, aimed at advancing operations and technology. The company plans to leverage this funding to enhance their product offerings and expand into new markets. Specific regions targeted for expansion have not been detailed, but the strategy includes increasing their presence in various healthcare sectors both domestically and internationally.

## Funding rounds

- Series B, Dec 1, 2022, $18M — Transformation Capital, Threshold Ventures
- Series A, Sep 30, 2021, $15M — First Round Capital, Transformation Capital, Threshold Ventures
- Seed, Apr 24, 2019, $5.2M — Quaker Partners Management, First Round Capital, SV Angel, Refactor Capital, Bragiel Brothers, Meridian Street Capital, Quake Capital Partners, Beijing Xinlong Capital Private Equity Fund Management Center

## Investors

- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Seed
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Seed, Series A
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Seed
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Seed
- Bragiel Brothers (https://capitalatlas.ai/funds/bragiel-brothers) — Seed
- Meridian Street Capital (https://capitalatlas.ai/funds/meridian-street-capital) — Seed
- Quake Capital Partners (https://capitalatlas.ai/funds/quake-capital-partners) — Seed
- Beijing Xinlong Capital Private Equity Fund Management Center (https://capitalatlas.ai/funds/beijing-xinlong-capital-private-equity-fund-management-cente) — Seed
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series A, Series B
- Threshold Ventures (https://capitalatlas.ai/funds/threshold-ventures) — Series A, Series B